FATTY ACID BETA DEGRADATION PATHWAY (PW:0000738)
Description
The degradation of fatty acids represents an essential source of energy; a major route is the mitochondrial beta-oxidation pathway. Before beta-oxidation can proceed, fatty acids need to be 'primed' or activated. The formation of fatty acyl-CoA thioesters is catalyzed by acyl-CoA synthetases in a two-step reaction. There are several acyl-CoA synthetases named after their chain length specificity. Once activated, acyl-CoAs need to reach the mitochondrial matrix where the enzymes of the beta-oxidation pathway are located. The acyl-CoAs, particularly the long-chain ones, cannot easily pass the mitochondrial inner membrane; their translocation is made possible by the CPT system. The acyl moiety is transferred from CoA to carnitine by Cpt1 - an integral membrane protein of the outer mitochondrial membrane. Note that Cpt1 is subject to inhibition by malonyl-CoA, the substrate for the fatty acid biosynthetic pathway. The translocase (Slc25a20) facilitates the translocation of acylcarnitine across the mitochondrial inner membrane where Cpt2 catalyzes the transfer of the acyl group from carnitine to CoA. The acyl-CoA thioesters can now undergo beta-oxidation. The beta-oxidation pathway, generally described as a spiral, consists of a [repeating] cycle of four reactions that produces acetyl-CoA and an acyl-CoA that is two carbon shorter. The spiral repeats itself until the entire acyl-CoA has been broken down to acetyl-CoA. In the first reaction, acyl-CoA is dehydrogenated to trans-2-enoyl-CoA by members of the FAD-containing acyl-CoA dehydrogenase family (Acad). The family contains several members named after their chain-length specificity; of these, the long-chain acyl-CoA dehydrogenase may participate in the beta-oxidation of unsaturated fatty acids. The FADH2 produced in the reaction is re-oxidized by transferring electrons from the dehydrogenase to the FAD group of Etf and from there to Etfdh which feeds the electrons into the electron transport chain thus linking the dehydrogenases to the oxidative phosphorylation pathway culminating in ATP synthesis. In the second reaction, 2-trans-enoyl-CoA is reversibly hydrated to 3-hydroxyacyl-CoA by Echs1. 3-hydroxyacyl-CoA undergoes NAD-dependent dehydrogenation to produce 3-ketoacyl-CoA, a reaction catalyzed by Hadh. The last step involves a thiolase-mediated (Acaa2) cleavage of the thioester bond to release acetyl-CoA and an acyl-CoA which is two carbons shorter and enters another round of the spiral. The last three steps of the beta-oxidation of long-chain acyl-CoA esters - the hydratase, dehydrogenase and thiolase reactions - are carried out by a trifunctional enzyme. While the mono-enzymes are soluble matrix proteins, the trifunctional enzyme is associated with the inner mitochondrial membrane. Disorders of the beta-oxidation pathway have been associated with several conditions.
To see the ontology report for GViewer, annotations and download, click here [Click to see the ontology report for associated GO term -
GO:0006635 , related Kegg map -
map00071 ]
...(less)
Pathway Diagram:
Genes in Pathway:
G
Abcd1
ATP binding cassette subfamily D member 1
ISO
SMPDB
SMP:00052
NCBI chr X:156,579,669...156,601,448
Ensembl chr X:156,579,785...156,601,446
G
Abcd2
ATP binding cassette subfamily D member 2
ISO
SMPDB
SMP:00052
NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202
G
Acaa2
acetyl-CoA acyltransferase 2
IDA ISO
SMPDB RGD
PMID:11879205
SMP:00480 SMP:00481 SMP:00482, RGD:2317624
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
G
Acad9
acyl-CoA dehydrogenase family, member 9
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709
G
Acadl
acyl-CoA dehydrogenase, long chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00480 SMP:00482, RGD:2317589 , RGD:2317678
NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164
G
Acadm
acyl-CoA dehydrogenase medium chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00481, RGD:2317589 , RGD:2317678
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
G
Acads
acyl-CoA dehydrogenase short chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00480, RGD:2317589 , RGD:2317678
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103
G
Acadvl
acyl-CoA dehydrogenase, very long chain
ISO IMP
RGD
PMID:14728676 PMID:15850553
RGD:2317589 , RGD:2317683
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750
G
Acat1
acetyl-CoA acetyltransferase 1
ISO
SMPDB
SMP:00480
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
SMPDB RGD
PMID:17762044
SMP:00052 SMP:00482, RGD:2317576
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
G
Acsl3
acyl-CoA synthetase long-chain family member 3
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
G
Acsl4
acyl-CoA synthetase long-chain family member 4
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
G
Acsl5
acyl-CoA synthetase long-chain family member 5
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
G
Acsl6
acyl-CoA synthetase long-chain family member 6
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,940,747...39,002,873
G
Acsm1
acyl-CoA synthetase medium-chain family member 1
ISO
SMPDB
SMP:00481
NCBI chr 1:183,417,052...183,451,897
Ensembl chr 1:183,416,009...183,454,217
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437
G
Acsm4
acyl-CoA synthetase medium-chain family member 4
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:183,485,259...183,509,712
Ensembl chr 1:183,485,259...183,509,712
G
Acss1
acyl-CoA synthetase short-chain family member 1
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
G
Acss2
acyl-CoA synthetase short-chain family member 2
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
G
Acss3
acyl-CoA synthetase short-chain family member 3
ISO
SMPDB
SMP:00480
NCBI chr 7:44,127,725...44,336,707
Ensembl chr 7:44,127,122...44,336,684
G
Cpt1a
carnitine palmitoyltransferase 1A
TAS ISO
SMPDB RGD
PMID:19430727
SMP:00482, RGD:2317584
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cpt1b
carnitine palmitoyltransferase 1B
ISO
RGD
PMID:19430727
RGD:2317584
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
G
Cpt2
carnitine palmitoyltransferase 2
TAS ISO
SMPDB RGD
PMID:19430727
SMP:00052 SMP:00482, RGD:2317584
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
G
Crat
carnitine O-acetyltransferase
ISO
SMPDB
SMP:00052
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099
G
Crot
carnitine O-octanoyltransferase
ISO
SMPDB
SMP:00052
NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064
G
Echs1
enoyl-CoA hydratase, short chain 1
IMP ISO
SMPDB RGD
PMID:12379132
SMP:00480 SMP:00481 SMP:00482, RGD:2317616
NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506
G
Etfa
electron transfer flavoprotein subunit alpha
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080
G
Etfb
electron transfer flavoprotein subunit beta
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659
G
Etfdh
electron transfer flavoprotein dehydrogenase
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770
G
Hadh
hydroxyacyl-CoA dehydrogenase
IMP ISO
SMPDB RGD
PMID:17491019
SMP:00480 SMP:00481 SMP:00482, RGD:2302227
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
SMPDB RGD
PMID:10816122
SMP:00481 SMP:00482, RGD:2317625
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
ISO
SMPDB RGD
PMID:10816122
SMP:00481 SMP:00482, RGD:2317625
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
ISO
SMPDB
SMP:00480
NCBI chr X:24,568,551...24,571,012
Ensembl chr X:24,568,551...24,574,681
G
Pex11g
peroxisomal biogenesis factor 11 gamma
ISO
SMPDB
SMP:00052
NCBI chr12:6,301,461...6,329,741
Ensembl chr12:6,277,664...6,318,919
G
Pex13
peroxisomal biogenesis factor 13
ISO
SMPDB
SMP:00052
NCBI chr14:101,804,673...101,822,367
Ensembl chr14:101,804,673...101,822,367
G
Pex14
peroxisomal biogenesis factor 14
ISO
SMPDB
SMP:00052
NCBI chr 5:164,682,876...164,819,352
Ensembl chr 5:164,682,715...164,819,352
G
Slc25a20
solute carrier family 25 member 20
ISO
SMPDB RGD
PMID:19430727
SMP:00052 SMP:00481 SMP:00482, RGD:2317584
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
Pathway Gene Annotations
Disease Annotations Associated with Genes in the fatty acid beta degradation pathway
Abcd1 Addison's disease , adrenoleukodystrophy , COVID-19 , Ehlers-Danlos syndrome kyphoscoliotic type 1 , encephalitis , genetic disease , intellectual disability , Nervous System Malformations , Neurologic Gait Disorders , peroxisome biogenesis disorder 2B , X-linked spondyloepimetaphyseal dysplasia Abcd2 Colorectal Neoplasms , hypothyroidism Acaa2 adult respiratory distress syndrome , basal cell carcinoma , osteoarthritis Acad9 genetic disease , mitochondrial complex I deficiency , nuclear type mitochondrial complex I deficiency 20 Acadl basal cell carcinoma , long chain 3-hydroxyacyl-CoA dehydrogenase deficiency , very long chain acyl-CoA dehydrogenase deficiency Acadm Congenital Hydrocephalus 2, with or without Brain or Eye Anomalies , genetic disease , Liver Failure , medium chain acyl-CoA dehydrogenase deficiency , metabolic dysfunction-associated steatotic liver disease , obesity , perinatal necrotizing enterocolitis , Weight Gain Acads alcohol use disorder , congestive heart failure , genetic disease , maturity-onset diabetes of the young type 1 , short chain acyl-CoA dehydrogenase deficiency , type 2 diabetes mellitus Acadvl Alzheimer's disease , Cardiac Arrhythmias , dilated cardiomyopathy , Experimental Diabetes Mellitus , genetic disease , glutaric acidemia I , Heat Stress Disorders , Hypoxia , metabolic dysfunction-associated steatotic liver disease , Metabolic Syndrome , myopathy , Pearson syndrome , Rhabdomyolysis , very long chain acyl-CoA dehydrogenase deficiency Acat1 arteriosclerosis , beta-ketothiolase deficiency , carbohydrate metabolic disorder , end stage renal disease , Experimental Liver Cirrhosis , genetic disease , nephrotic syndrome , steatotic liver disease Acsl1 Animal Mammary Neoplasms , carcinoma , cardiomyopathy , Chemical and Drug Induced Liver Injury , Experimental Arthritis , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Experimental Mammary Neoplasms , Insulin Resistance , obesity , Starvation Acsl3 asthma , breast cancer , Experimental Allergic Asthma , Experimental Diabetes Mellitus , Inflammation , lung cancer , prostate cancer , Sudden Cardiac Death Acsl4 Animal Disease Models , autism spectrum disorder , depressive disorder , Erythema , Experimental Arthritis , genetic disease , hepatocellular carcinoma , Inflammation , intellectual disability , lung adenocarcinoma , non-syndromic X-linked intellectual disability , non-syndromic X-linked intellectual disability 63 , Prostatic Neoplasms Acsl5 Diarrhea 13 , Experimental Arthritis Acsl6 acute myeloid leukemia , amphetamine abuse , Experimental Diabetes Mellitus , Hereditary Neoplastic Syndromes , Inflammation , leukemia , myelodysplastic syndrome Acsm1 Lung Neoplasms Acsm3 abdominal obesity-metabolic syndrome , essential hypertension , hypertension , IgA glomerulonephritis , ocular hypertension , Overweight , Prostatic Neoplasms , ulcerative colitis Acss1 Experimental Melanoma , Hypothermia Acss2 Experimental Melanoma , Inflammation , lymphangioleiomyomatosis , morbid obesity , orofacial cleft Cpt1a alcoholic hepatitis , atherosclerosis , Breast Neoplasms , Cardiac Fibrosis , Cardiotoxicity , carnitine palmitoyltransferase I deficiency , Chemical and Drug Induced Liver Injury , Chronic Hepatitis C , diabetes mellitus , disease of metabolism , end stage renal disease , Experimental Diabetes Mellitus , genetic disease , Hypoxia , lipid metabolism disorder , lymphangioleiomyomatosis , metabolic dysfunction and alcohol associated liver disease , metabolic dysfunction-associated steatohepatitis , metabolic dysfunction-associated steatotic liver disease , obesity , type 2 diabetes mellitus Cpt1b Cardiomegaly , Experimental Diabetes Mellitus , Liver Neoplasms , Myocardial Ischemia , narcolepsy Cpt2 brain disease , carnitine palmitoyltransferase II deficiency , Carnitine Palmitoyltransferase II Deficiency, Infantile , Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal , Encephalopathy, acute, infection-induced, 4 , epilepsy , Flatfoot , genetic disease , Genu Valgum , Late-Onset Carnitine Palmitoyltransferase II Deficiency , lipid metabolism disorder , Metabolic Brain Diseases , microcephaly , Muscle Hypotonia , muscular disease , myopathy , Nervous System Malformations , Rhabdomyolysis Crat Carnitine Acetyltransferase Deficiency , neurodegeneration with brain iron accumulation , Neurodegeneration with Brain Iron Accumulation 8 Crot Experimental Liver Cirrhosis , Left Ventricular Hypertrophy Echs1 Chemical and Drug Induced Liver Injury , genetic disease , Leigh disease , mitochondrial short-chain enoyl-CoA hydratase 1 deficiency , obesity , Stomach Neoplasms Etfa genetic disease , glutaric acidemia type 3 , Glutaric Aciduria 2 , hepatocellular carcinoma , multiple acyl-CoA dehydrogenase deficiency , osteoarthritis Etfb chronic kidney disease , genetic disease , multiple acyl-CoA dehydrogenase deficiency Etfdh disease of metabolism , genetic disease , hypertrophic cardiomyopathy , megacolon , multiple acyl-CoA dehydrogenase deficiency , myopathy , obesity , spinal muscular atrophy Hadh 3-Hydroxyacyl-CoA Dehydrogenase Deficiency , Congenital Hyperinsulinism , diabetes mellitus , Experimental Diabetes Mellitus , familial hyperinsulinemic hypoglycemia 1 , familial hyperinsulinemic hypoglycemia 4 , genetic disease , hyperinsulinemic hypoglycemia , hyperinsulinism , myocardial infarction , obesity , pre-malignant neoplasm Hadha Alzheimer's disease , Chemical and Drug Induced Liver Injury , COVID-19 , Experimental Diabetes Mellitus , Fetal Growth Retardation , genetic disease , long chain 3-hydroxyacyl-CoA dehydrogenase deficiency , metabolic dysfunction-associated steatotic liver disease , mitochondrial trifunctional protein deficiency , mitochondrial trifunctional protein deficiency 1 , Myocardial Ischemia , osteoarthritis , steatotic liver disease Hadhb Alzheimer's disease , Breast Neoplasms , Charcot-Marie-Tooth disease , COVID-19 , genetic disease , heart disease , lipid metabolism disorder , metabolic acidosis , mitochondrial metabolism disease , mitochondrial trifunctional protein deficiency , mitochondrial trifunctional protein deficiency 1 , mitochondrial trifunctional protein deficiency 2 , steatotic liver disease Hsd17b10 Alzheimer's disease , azoospermia , COVID-19 , genetic disease , lung adenocarcinoma , osteosarcoma , pheochromocytoma , syndromic X-linked intellectual disability type 10 Pex13 adrenoleukodystrophy , genetic disease , infantile Refsum disease , peroxisomal biogenesis disorder , peroxisome biogenesis disorder 11A , Peroxisome biogenesis disorder 11B , peroxisome biogenesis disorder 1A , Zellweger syndrome Pex14 genetic disease , ovarian cyst , peroxisomal biogenesis disorder , peroxisome biogenesis disorder 13A , peroxisome biogenesis disorder 1A , Peroxisome Biogenesis Disorder, Complementation Group K , Zellweger syndrome Slc25a20 autism spectrum disorder , carnitine-acylcarnitine translocase deficiency , genetic disease
3-Hydroxyacyl-CoA Dehydrogenase Deficiency Hadh abdominal obesity-metabolic syndrome Acsm3 acute myeloid leukemia Acsl6 Addison's disease Abcd1 adrenoleukodystrophy Abcd1 , Pex13 adult respiratory distress syndrome Acaa2 alcohol use disorder Acads alcoholic hepatitis Cpt1a Alzheimer's disease Acadvl , Hadha , Hadhb , Hsd17b10 amphetamine abuse Acsl6 Animal Disease Models Acsl4 Animal Mammary Neoplasms Acsl1 arteriosclerosis Acat1 asthma Acsl3 atherosclerosis Cpt1a autism spectrum disorder Acsl4 , Slc25a20 azoospermia Hsd17b10 basal cell carcinoma Acaa2 , Acadl beta-ketothiolase deficiency Acat1 brain disease Cpt2 breast cancer Acsl3 Breast Neoplasms Cpt1a , Hadhb carbohydrate metabolic disorder Acat1 carcinoma Acsl1 Cardiac Arrhythmias Acadvl Cardiac Fibrosis Cpt1a Cardiomegaly Cpt1b cardiomyopathy Acsl1 Cardiotoxicity Cpt1a Carnitine Acetyltransferase Deficiency Crat carnitine palmitoyltransferase I deficiency Cpt1a carnitine palmitoyltransferase II deficiency Cpt2 Carnitine Palmitoyltransferase II Deficiency, Infantile Cpt2 Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal Cpt2 carnitine-acylcarnitine translocase deficiency Slc25a20 Charcot-Marie-Tooth disease Hadhb Chemical and Drug Induced Liver Injury Acsl1 , Cpt1a , Echs1 , Hadha Chronic Hepatitis C Cpt1a chronic kidney disease Etfb Colorectal Neoplasms Abcd2 Congenital Hydrocephalus 2, with or without Brain or Eye Anomalies Acadm Congenital Hyperinsulinism Hadh congestive heart failure Acads COVID-19 Abcd1 , Hadha , Hadhb , Hsd17b10 depressive disorder Acsl4 diabetes mellitus Cpt1a , Hadh Diarrhea 13 Acsl5 dilated cardiomyopathy Acadvl disease of metabolism Cpt1a , Etfdh Ehlers-Danlos syndrome kyphoscoliotic type 1 Abcd1 encephalitis Abcd1 Encephalopathy, acute, infection-induced, 4 Cpt2 end stage renal disease Acat1 , Cpt1a epilepsy Cpt2 Erythema Acsl4 essential hypertension Acsm3 Experimental Allergic Asthma Acsl3 Experimental Arthritis Acsl1 , Acsl4 , Acsl5 Experimental Diabetes Mellitus Acadvl , Acsl1 , Acsl3 , Acsl6 , Cpt1a , Cpt1b , Hadh , Hadha Experimental Liver Cirrhosis Acat1 , Acsl1 , Crot Experimental Mammary Neoplasms Acsl1 Experimental Melanoma Acss1 , Acss2 familial hyperinsulinemic hypoglycemia 1 Hadh familial hyperinsulinemic hypoglycemia 4 Hadh Fetal Growth Retardation Hadha Flatfoot Cpt2 genetic disease Abcd1 , Acad9 , Acadm , Acads , Acadvl , Acat1 , Acsl4 , Cpt1a , Cpt2 , Echs1 , Etfa , Etfb , Etfdh , Hadh , Hadha , Hadhb , Hsd17b10 , Pex13 , Pex14 , Slc25a20 Genu Valgum Cpt2 glutaric acidemia I Acadvl glutaric acidemia type 3 Etfa Glutaric Aciduria 2 Etfa heart disease Hadhb Heat Stress Disorders Acadvl hepatocellular carcinoma Acsl4 , Etfa Hereditary Neoplastic Syndromes Acsl6 hyperinsulinemic hypoglycemia Hadh hyperinsulinism Hadh hypertension Acsm3 hypertrophic cardiomyopathy Etfdh Hypothermia Acss1 hypothyroidism Abcd2 Hypoxia Acadvl , Cpt1a IgA glomerulonephritis Acsm3 infantile Refsum disease Pex13 Inflammation Acsl3 , Acsl4 , Acsl6 , Acss2 Insulin Resistance Acsl1 intellectual disability Abcd1 , Acsl4 Late-Onset Carnitine Palmitoyltransferase II Deficiency Cpt2 Left Ventricular Hypertrophy Crot Leigh disease Echs1 leukemia Acsl6 lipid metabolism disorder Cpt1a , Cpt2 , Hadhb Liver Failure Acadm Liver Neoplasms Cpt1b long chain 3-hydroxyacyl-CoA dehydrogenase deficiency Acadl , Hadha lung adenocarcinoma Acsl4 , Hsd17b10 lung cancer Acsl3 Lung Neoplasms Acsm1 lymphangioleiomyomatosis Acss2 , Cpt1a maturity-onset diabetes of the young type 1 Acads medium chain acyl-CoA dehydrogenase deficiency Acadm megacolon Etfdh metabolic acidosis Hadhb Metabolic Brain Diseases Cpt2 metabolic dysfunction and alcohol associated liver disease Cpt1a metabolic dysfunction-associated steatohepatitis Cpt1a metabolic dysfunction-associated steatotic liver disease Acadm , Acadvl , Cpt1a , Hadha Metabolic Syndrome Acadvl microcephaly Cpt2 mitochondrial complex I deficiency Acad9 mitochondrial metabolism disease Hadhb mitochondrial short-chain enoyl-CoA hydratase 1 deficiency Echs1 mitochondrial trifunctional protein deficiency Hadha , Hadhb mitochondrial trifunctional protein deficiency 1 Hadha , Hadhb mitochondrial trifunctional protein deficiency 2 Hadhb morbid obesity Acss2 multiple acyl-CoA dehydrogenase deficiency Etfa , Etfb , Etfdh Muscle Hypotonia Cpt2 muscular disease Cpt2 myelodysplastic syndrome Acsl6 myocardial infarction Hadh Myocardial Ischemia Cpt1b , Hadha myopathy Acadvl , Cpt2 , Etfdh narcolepsy Cpt1b nephrotic syndrome Acat1 Nervous System Malformations Abcd1 , Cpt2 neurodegeneration with brain iron accumulation Crat Neurodegeneration with Brain Iron Accumulation 8 Crat Neurologic Gait Disorders Abcd1 non-syndromic X-linked intellectual disability Acsl4 non-syndromic X-linked intellectual disability 63 Acsl4 nuclear type mitochondrial complex I deficiency 20 Acad9 obesity Acadm , Acsl1 , Cpt1a , Echs1 , Etfdh , Hadh ocular hypertension Acsm3 orofacial cleft Acss2 osteoarthritis Acaa2 , Etfa , Hadha osteosarcoma Hsd17b10 ovarian cyst Pex14 Overweight Acsm3 Pearson syndrome Acadvl perinatal necrotizing enterocolitis Acadm peroxisomal biogenesis disorder Pex13 , Pex14 peroxisome biogenesis disorder 11A Pex13 Peroxisome biogenesis disorder 11B Pex13 peroxisome biogenesis disorder 13A Pex14 peroxisome biogenesis disorder 1A Pex13 , Pex14 peroxisome biogenesis disorder 2B Abcd1 Peroxisome Biogenesis Disorder, Complementation Group K Pex14 pheochromocytoma Hsd17b10 pre-malignant neoplasm Hadh prostate cancer Acsl3 Prostatic Neoplasms Acsl4 , Acsm3 Rhabdomyolysis Acadvl , Cpt2 short chain acyl-CoA dehydrogenase deficiency Acads spinal muscular atrophy Etfdh Starvation Acsl1 steatotic liver disease Acat1 , Hadha , Hadhb Stomach Neoplasms Echs1 Sudden Cardiac Death Acsl3 syndromic X-linked intellectual disability type 10 Hsd17b10 type 2 diabetes mellitus Acads , Cpt1a ulcerative colitis Acsm3 very long chain acyl-CoA dehydrogenase deficiency Acadl , Acadvl Weight Gain Acadm X-linked spondyloepimetaphyseal dysplasia Abcd1 Zellweger syndrome Pex13 , Pex14